Artificial Intelligent‐Enhanced Metabolite Profiling for Intraoperative IDH1 Genotyping in Glioma Using an Orthogonally Responsive SERS Probe
Advanced Science · 2025-07 · 12 (26)
DOI: 10.1002/advs.202503360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.04.2025. Verfasst von Hang Yin und 14 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, School of Pharmacy, Fudan …. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Glioma, Spectrum Analysis, Raman, Brain Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, Shanghai Health Commission Emerging Cross Disciplinary Research Project.
Abstract (Originalsprache)
Intraoperative identification of the isocitrate dehydrogenase type 1 (IDH1) genotype, a key molecular marker in glioma, is essential for optimizing surgical strategies and tailoring post‐surgical treatments. However, current clinical practices lack effective methods for real‐time IDH1 genotype detection during surgery. Here, a novel strategy is proposed for intraoperative IDH1 genotype identification by simultaneously measuring two redox‐related metabolites. A surface‐enhanced Raman scattering (SERS) probe is developed to detect glutathione and hydrogen peroxide concentrations through orthogonally responsive Raman signals. Additionally, a deep learning algorithm is implemented, leveraging 2D Raman spectra transformation and multi‐task learning to enhance measurement speed and accuracy. This AI‐assisted SERS approach can identify the IDH1 genotype in glioma patients within 7 min. In a cohort of 31 glioma patients, the system achieved an area under the receiver operating characteristic curve of 0.985 for accurate IDH1 genotype differentiation. This study holds significant promise for refining surgical decision‐making and personalizing post‐surgical treatments by enabling rapid intra‐operative molecular biomarker identification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Key Laboratory of Smart Drug Delivery, MOE Innovative Center for New Drug Development of Immune Inflammatory Diseases, School of Pharmacy, Fudan University, Shanghai, 201203, China.
- Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, National Center for Neurological Disorders, Shanghai Key Laboratory of Brain Function and Restoration and Neural Regeneration, Ne…
- School of Information Science and Technology, Fudan University, Shanghai, 200433, China.
- Department of Ophthalmology, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200011, China.
- Artificial Intelligence Innovation and Incubation Institute, Fudan University, Shanghai, 200433, China.
- Zhongshan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, 200032, China.
ORCID-Profile: Cong Li
Förderung
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Shanghai Health Commission Emerging Cross Disciplinary Research Project
- Science and Technology Commission of Shanghai Municipality
- Shanghai Rising-Star Program
- Greater Bay Area Institute of Precision Medicine
- National Key Research and Development Program of China
Zitieren
APA
Yin, H., Zhang, X., Zhao, Z., Cao, C., Xu, M., Zhou, S., Xuan, T., Jin, Z., Han, L., Fan, Y., Wang, C., Zhu, X., Mao, Y., Yu, J., & Li, C. (2025). Artificial Intelligent‐Enhanced Metabolite Profiling for Intraoperative IDH1 Genotyping in Glioma Using an Orthogonally Responsive SERS Probe. Advanced Science, 12(26). https://doi.org/10.1002/advs.202503360
Vancouver
Yin H, Zhang X, Zhao Z, Cao C, Xu M, Zhou S, et al. Artificial Intelligent‐Enhanced Metabolite Profiling for Intraoperative IDH1 Genotyping in Glioma Using an Orthogonally Responsive SERS Probe. Advanced Science. 2025;12(26). doi:10.1002/advs.202503360
BibTeX
@article{Yin2025,
author = {Yin, Hang and Zhang, Xin and Zhao, Zheng and Cao, Chong and Xu, Minhua and Zhou, Suhongrui and Xuan, Tian and Jin, Ziyi and Han, Limei and Fan, Yang and Wang, Cong and Zhu, Xiao and Mao, Ying and Yu, Jinhua and Li, Cong},
title = {Artificial Intelligent‐Enhanced Metabolite Profiling for Intraoperative IDH1 Genotyping in Glioma Using an Orthogonally Responsive SERS Probe},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {26},
doi = {10.1002/advs.202503360}
}
EUVIMED